BAYTRIL 10% Oral solution 1 L - Oral suspension for chickens, turkeys and rabbits.

BAYTRIL 10% Oral solution 1 L - Oral suspension for chickens, turkeys and rabbits.

Pet Shop Luna SRL

€ 199.99 

Baytril 10% Oral solution 1 L - Oral suspension for chickens and turkeys, anti-infective used in the treatment of infections caused by bacteria and mycoplasmas.

Composition

  • Active substance: Enrofloxacin: 100 mg/ml;
  • Excipients: Benzyl alcohol (preservative).

Directions

  • Anti-infective used in the treatment of infections caused by bacteria and mycoplasmas in chickens and turkeys or mixed and secondary infections in viral diseases caused by mycoplasmas and the following gram-negative bacteria and gram-positive bacteria sensitive to enrofloxacin: Haemophilus paragallinarum (avian infectious coryza), Pasteurella , E. coli, Salmonella, Staphylococcus, Erysipelothrix rhusiopathiae.
  • The goals of therapy are to reduce the clinical signs of salmonellosis and to reduce mortality simultaneously with the decrease in the excretion of salmonella, being achieved after a few weeks of using Baytril®. Eradication of salmonella and mycoplasma is not achieved by treatment with Baytril®.

Contraindications

The existence of resistance to quinolones, that this resistance is often almost complete, and also cross-resistance with other fluoroquinolones. Due to a weak sensitivity of streptococci to enrofloxacin, BAYTRIL® 10% ORAL SOLUTION is not indicated in streptococcal infections. Not for use in birds that produce eggs for human consumption.

Side effects

  • The use of fluoroquinolones during the growth phases of the birds combined with an increase in the consumption of water and hence of the active substance, possibly due to high temperatures, can be associated with articular cartilage disorders that will manifest in disorders of the locomotor system.
  • If you notice serious reactions or other effects not mentioned in this leaflet, please inform your veterinarian.

Target species Chickens and turkeys.

Dosage for each species, route of administration and mode of administration

As a general rule, the dosage in birds of this age or older that have a lower water consumption relative to body mass eg: older broilers, older turkeys and pullets, should not be less than 10 mg enrofloxacin / kg live weight per day

  • 50 ml Baytril® 10 % / 100 liters of drinking water = 5 g enrofloxacin / 100 liters of drinking water (= 50 ppm) for the following categories and ages:
  • Broilers (chickens for meat), fattening turkeys 1 - 3 weeks.
  • Broiler queen, laying hen queen 1 - 5 weeks.

In the presence of salmonellosis, mixed infections or chronic forms, the following doses are indicated for broilers (broilers), fattening turkeys and queens for broilers from the age of 3 weeks and queens for laying hens from the age of 5 weeks:

100 ml Baytril® 10 % / 100 liters of drinking water = 10 g enrofloxacin / 100 liters of drinking water (= 100 ppm).

Method of administration For administration in drinking water.

Duration of treatment:

The treatment is applied three to five consecutive days, and in salmonellosis, mixed infections and chronic forms five consecutive days. If after two to three days there is no obvious improvement, the sensitivity test will have to be checked again and if necessary a change of therapy is indicated.

Withdrawal time Edible tissues: chickens and turkeys: 3 days.

Special precautions for storage

  • Keep out of reach of children.
  • Protect from direct light.
  • Do not use after the expiry date marked on the label after {EXP}.

Validity period after the first opening of the container : 3 months.

Shelf life after dilution or reconstitution according to the indications : 2 days.

Special warnings

Special precautions for use in animals

  • Official and local conditions regarding the use of antimicrobial products shall be taken into account when using the product.
  • Fluoroquinolones should be reserved for clinical treatment when they have responded poorly or are expected to respond poorly to other classes of antimicrobials. Whenever possible, fluoroquinolones should be used only on the basis of susceptibility testing.
  • Use of the product with deviations from the instructions given in the SPC may increase the prevalence of bacteria resistant to fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to cross-resistance.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In case of contact with skin or eyes, wash immediately with plenty of water. It is forbidden to consume food and drink, as well as to smoke, while using the product.

Use during the laying period

  • Not for use in birds that produce eggs for human consumption.
  • Interactions with other medicinal products or other forms of interaction
  • Combining Baytril® (enrofloxacin) with macrolides or tetracyclines causes antagonistic effects.
  • Concomitant administration with substances containing magnesium or aluminum can reduce the absorption of enrofloxacin.

Overdose (symptoms, emergency procedures, antidotes), as appropriate: Fluoroquinolone poisoning can cause nausea, vomiting and diarrhea.

incompatibility

  • Mixing Baytril® solution with Marek's disease vaccine may impair the pharmaceutical quality of the vaccine.
  • Special precautions for disposal of unused product or waste, as appropriate
  • Medicines must not be thrown into waste water or household waste.
  • Ask your veterinarian for information on how to dispose of medications that are no longer needed. These measures contribute to the protection of the environment.

Other information

  • Official and local conditions regarding the use of antimicrobial products shall be taken into account when using the product.
  • Fluoroquinolones should be reserved for clinical treatment when they have responded poorly or are expected to respond poorly to other classes of antimicrobials.
  • Whenever possible, fluoroquinolones should be used only on the basis of susceptibility testing.
  • Use of the product with deviations from the instructions given in the SPC may increase the prevalence of bacteria resistant to fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to cross-resistance.